Profil

Blomme Arnaud

GIGA Stem Cells - Cancer Signaling

Département de pharmacie

See author's contact details
ORCID
0000-0003-4183-8726
Main Referenced Co-authors
Castronovo, Vincenzo  (50)
Turtoi, Andrei  (35)
Delvenne, Philippe  (26)
Peixoto, Paul  (22)
De Tullio, Pascal  (21)
Main Referenced Keywords
Cancer (17); HDAC5 (12); Metabolism (12); Proteomics (4); Alternative oxidase (2);
Main Referenced Unit & Research Centers
Giga-Cancer - ULiège [BE] (3)
GIGA CRC (Cyclotron Research Center) In vivo Imaging-Aging & Memory - ULiège [BE] (2)
GIGA‐R - Giga‐Research - ULiège [BE] (1)
Laboratoire de recherche sur les métastases (1)
Laboratoire recherche sur les Métastases (1)
Main Referenced Disciplines
Oncology (34)
Biochemistry, biophysics & molecular biology (23)
Life sciences: Multidisciplinary, general & others (12)
Surgery (8)
Gastroenterology & hepatology (4)

Publications (total 66)

The most downloaded
570 downloads
Martinez, R. S., Salji, M. J., Rushworth, L., Ntala, C., Rodriguez Blanco, G., Hedley, A., Clark, W., Peixoto, P., Hervouet, E., Renaude, E., Kung, S. H. Y., Galbraith, L. C. A., Nixon, C., Lilla, S., Mackay, G. M., Fazli, L., Gaughan, L., Sumpton, D., Gleave, M. E., ... Leung, H. Y.*. (2021). SLFN5 regulates LAT1-mediated mTOR activation in castration-resistant prostate cancer. Cancer Research. doi:10.1158/0008-5472.CAN-20-3694 https://hdl.handle.net/2268/260616

The most cited

101 citations (Scopus®)

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Turtoi, A., Costanza, B., Smargiasso, N., Baiwir, D., Scheijen, J., Schalkwijk, C., Leenders, J., De Tullio, P., BIANCHI, E., Thiry, M., Uchida, K., Spiegel, D., Cochrane, J., ... Bellahcene, A. (2016). Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP- mediated tumor growth and metastasis. eLife. doi:10.7554/eLife.19375 https://hdl.handle.net/2268/207276

Crake, R., Kiweler, N., Thiry, M., Peulen, O., Blomme, A., Meiser, J., Ambrogio, C., Santamaria, D., Cataldo, D., & Nokin, M.-J. (June 2023). Targeting metabolic adaptations in drug tolerant BRAFV600E mutant NSCLC [Poster presentation]. EACR 2023, Torino, Italy.

Largeot, A., Klapp, V., Viry, E., Gonder, S., Fernandez Botana, I., Blomme, A., Benzarti, M., Pierson, S., Duculty, C., Marttila, P., Wierz, M., Gargiulo, E., Pagano, G., An, N., El Hachem, N., Perez Hermandez, D., Chakraborty, S., Ysebaert, L., François, J.-H., ... Moussay, E. (2023). Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as therapeutic strategy in CLL. Blood. doi:10.1182/blood.2022017839
Peer Reviewed verified by ORBi

Almanza, A.* , Mnich, K.* , Blomme, A., Robinson, C. M., Rodriguez-Blanco, G., Kierszniowska, S., McGrath, E. P., Le Gallo, M., Pilalis, E., Swinnen, J. V., Chatziioannou, A., Chevet, E., Gorman, A. M., & Samali, A. (06 May 2022). Regulated IRE1α-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancer. Nature Communications, 13 (1), 2493. doi:10.1038/s41467-022-30159-0
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Salji, M. J., Blomme, A., Däbritz, J. H. M., Repiscak, P., Lilla, S., Patel, R., Sumpton, D., van den Broek, N. J. F., Daly, R., Zanivan, S., & Leung, H. Y. (15 April 2022). Multi-omics & pathway analysis identify potential roles for tumor N-acetyl aspartate accumulation in murine models of castration-resistant prostate cancer. iScience, 25 (4), 104056. doi:10.1016/j.isci.2022.104056
Peer Reviewed verified by ORBi

Blomme, A., Peter, C., Mui, E., Rodriguez Blanco, G., An, N., Mason, L. M., Jamieson, L. E., McGregor, G. H., Lilla, S., Ntala, C., Patel, R., Thiry, M., Kung, S. H. Y., Leclercq, M., Ford, C. A., Rushworth, L. K., McGarry, D. J., Mason, S., Repiscak, P., ... Leung, H. Y. (2022). THEM6-mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer. EMBO Molecular Medicine, 14764. doi:10.15252/emmm.202114764
Peer Reviewed verified by ORBi

Martinez, R. S., Salji, M. J., Rushworth, L., Ntala, C., Rodriguez Blanco, G., Hedley, A., Clark, W., Peixoto, P., Hervouet, E., Renaude, E., Kung, S. H. Y., Galbraith, L. C. A., Nixon, C., Lilla, S., Mackay, G. M., Fazli, L., Gaughan, L., Sumpton, D., Gleave, M. E., ... Leung, H. Y.*. (2021). SLFN5 regulates LAT1-mediated mTOR activation in castration-resistant prostate cancer. Cancer Research. doi:10.1158/0008-5472.CAN-20-3694
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Chiavarina, B., Costanza, B., Ronca, R., Blomme, A., Rezzola, S., Chiodelli, P., Giguelay, A., Belthier, G., Doumont, G., Van Simaeys, G., Lacroix, S., Yokobori, T., Erkhem-Ochir, B., Balaguer, P., Cavailles, V., Fabbrizio, E., Di Valentin, E., Gofflot, S., Detry, O., ... Turtoi, A. (January 2021). Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis. Theranostics, 11 (4), 1626-1640. doi:10.7150/thno.51507
Peer Reviewed verified by ORBi

Ntala, C., Salji, M., Salmond, J., Officer, L., Teodosio, A. V., Blomme, A., McGhee, E. J., Powley, I., Ahmad, I., Kruithof-de Julio, M., Thalmann, G., Roberts, E., Goodyear, C. S., Jamaspishvili, T., Berman, D. M., Carlin, L. M., Le Quesne, J., & Leung, H. Y. (2021). Analysis of Prostate Cancer Tumor Microenvironment Identifies Reduced Stromal CD4 Effector T-cell Infiltration in Tumors with Pelvic Nodal Metastasis. European urology open science, 29, 19-29. doi:10.1016/j.euros.2021.05.001
Peer reviewed

Moncan, M., Mnich, K., Blomme, A., Almanza, A., Samali, A., & Gorman, A. M. (2021). Regulation of lipid metabolism by the unfolded protein response. Journal of Cellular and Molecular Medicine, 25 (3), 1359-1370. doi:10.1111/jcmm.16255
Peer Reviewed verified by ORBi

Bellier, J., Nokin, M.-J., Caprasse, M., Tiamiou, A., Blomme, A., Scheijen, J. L., KOOPMANSCH, B., MacKay, G. M., Chiavarina, B., Costanza, B., Rademaker, G., Durieux, F., Agirman, F., Maloujahmoum, N., Cusumano, P. G., LOVINFOSSE, P., Leung, H. Y., LAMBERT, F., Bours, V., ... Bellahcene, A. (04 February 2020). Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab. Cell Reports, 30 (5), 1400-1416.e6. doi:10.1016/j.celrep.2020.01.012
Peer Reviewed verified by ORBi

Blomme, A., Ford, C. A., Mui, E., Patel, R., Ntala, C., Jamieson, L. E., Planque, M., McGregor, G. H., Peixoto, P., Hervouet, E., Nixon, C., Salji, M., Gaughan, L., Markert, E., Repiscak, P., Sumpton, D., Blanco, G. R., Lilla, S., Kamphorst, J. J., ... Leung, H. Y. (2020). 2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer. Nature Communications, 11 (1), 2508. doi:10.1038/s41467-020-16126-7
Peer Reviewed verified by ORBi

Patel, R., Brzezinska, E. A., Repiscak, P., Ahmad, I., Mui, E., Gao, M., Blomme, A., Harle, V., Tan, E. H., Malviya, G., Mrowinska, A., Loveridge, C. J., Rushworth, L. K., Edwards, J., Ntala, C., Nixon, C., Hedley, A., Mackay, G., Tardito, S., ... Leung, H. Y. (2020). Activation of β-Catenin Cooperates with Loss of Pten to Drive AR-Independent Castration-Resistant Prostate Cancer. Cancer Research, 80 (3), 576-590. doi:10.1158/0008-5472.CAN-19-1684
Peer Reviewed verified by ORBi

Costanza, B., Rademaker, G., Tiamiou, A., De Tullio, P., Leenders, J., Blomme, A., Bellier, J., Bianchi, E., Turtoi, A., Delvenne, P., Bellahcene, A., Peulen, O.* , & Castronovo, V.*. (2019). TGFBI, an ECM interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration. International Journal of Cancer. doi:10.1002/ijc.32247
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Blomme, A., van Simaeys, G., Doumont, G., Costanza, B., Bellier, J., Otaka, Y., Sherer, F., LOVINFOSSE, P., Boutry, S., Palacios, A. P., De Pauw, E., Hirano, T., Yokobori, T., Hustinx, R., Bellahcene, A., Delvenne, P., DETRY, O., Goldman, S., Nishiyama, M., ... Turtoi, A. (March 2018). Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases. Oncogene, 37 (9), 1237-1250. doi:10.1038/s41388-017-0018-x
Peer Reviewed verified by ORBi

Patel, R., Fleming, J., Mui, E., Loveridge, C., Repiscak, P., Blomme, A., Harle, V., Salji, M., Ahmad, I., Teo, K., Hamdy, F. C., Hedley, A., van den Broek, N., Mackay, G., Edwards, J., Sansom, O. J., & Leung, H. Y. (2018). Sprouty2 loss-induced IL6 drives castration-resistant prostate cancer through scavenger receptor B1. EMBO Molecular Medicine, 10 (4). doi:10.15252/emmm.201708347
Peer Reviewed verified by ORBi

Costanza, B., Turtoi, A., Bellahcene, A., Hirano, T., Peulen, O., Blomme, A., Hennequiere, J., MUTIJIMA NZARAMBA, E., Boniver, J., Meuwis, M.-A., JOSSE, C., KOOPMANSCH, B., SEGERS, K., Yokobori, T., Fahmy, K., Thiry, M., COIMBRA MARQUES, C., Garbacki, N., Colige, A., ... Castronovo, V. (2018). Innovative methodology for the identification of soluble biomarkers in fresh tissues. Oncotarget, 9 (12), 10665-10680. doi:10.18632/oncotarget.24366
Peer Reviewed verified by ORBi

Hendrick, E., Peixoto, P., Blomme, A., Polese, C., Matheus, N., Cimino, J., Frère, A., Mouithys-Mickalad, A., Serteyn, D., Bettendorff, L., Elmoualij, B., De Tullio, P., Eppe, G., Dequiedt, F., Castronovo, V., & Mottet, D. (2017). Metabolic inhibitors accentuate the anti-tumoral effect of HDAC5 inhibition. Oncogene. doi:10.1038/onc.2017.103
Peer Reviewed verified by ORBi

Blomme, A., Fahmy, K., Peulen, O., Costanza, B., Fontaine, M., Struman, I., Baiwir, D., De Pauw, E., Thiry, M., Bellahcene, A., Castronovo, V.* , & Turtoi, A.*. (2016). Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes. Oncotarget. doi:10.18632/oncotarget.13276
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Blomme, A., Costanza, B., De Tullio, P., Thiry, M., Van Simaeys, G., Boutry, S., Doumont, G., Di Valentin, E., Hirano, T., Yokobori, T., GOFFLOT, S., Peulen, O., Bellahcene, A., Sherer, F., Le Goff, C., Cavalier, E., Mouithys-Mickalad, A., Jouret, F., CUSUMANO, G., ... Turtoi, A. (2016). Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer. Oncogene. doi:10.1038/onc.2016.369
Peer Reviewed verified by ORBi

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Turtoi, A., Costanza, B., Smargiasso, N., Baiwir, D., Scheijen, J., Schalkwijk, C., Leenders, J., De Tullio, P., BIANCHI, E., Thiry, M., Uchida, K., Spiegel, D., Cochrane, J., ... Bellahcene, A. (2016). Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP- mediated tumor growth and metastasis. eLife. doi:10.7554/eLife.19375
Peer Reviewed verified by ORBi

Henry, A., Nokin, M.-J., Leroi, N., Lallemand, F., Lambert, J., Goffart, N., RONCARATI, P., BIANCHI, E., Peixoto, P., Blomme, A., Turtoi, A., Peulen, O., Habraken, Y., Scholtes, F., Martinive, P., Delvenne, P., Rogister, B., Castronovo, V., & Bellahcene, A. (2016). New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity. Oncotarget. doi:10.18632/oncotarget.11483
Peer Reviewed verified by ORBi

Henry, A., Nokin, M.-J., Leroi, N., LALLEMAND, F., Lambert, J., Goffart, N., Peixoto, P., Blomme, A., BIANCHI, E., Habraken, Y., RONCARATI, P., Peulen, O., SCHOLTES, F., MARTINIVE, P., Rogister, B., Delvenne, P., Turtoi, A., Castronovo, V., & Bellahcene, A. (22 March 2016). Osteopontin predicts radiotherapy response of glioblastoma patients : new role in DNA damage repair [Paper presentation]. 3rd Symposium on small animal precision image-guided radiotherapy, Gand, Belgium.

Blomme, A., Cusumano, P., Peulen, O., Bellahcene, A., Castronovo, V., & Turtoi, A. (2016). L'asporine : une nouvelle defense naturelle contre le cancer du sein. MS. Medecine Sciences, 32 (11), 1019-1022. doi:10.1051/medsci/20163211020
Peer Reviewed verified by ORBi

Peixoto, P.* , Blomme, A.* , Costanza, B.* , Ronca, R., Rezzola, S., Palacios, A., SCHOYSMAN, L., Boutry, S., Goffart, N., Peulen, O., Maris, P., Di Valentin, E., Hennequière, V., BIANCHI, E., Henry, A., Meunier, P., Rogister, B., MULLER, R., Delvenne, P., ... Turtoi, A. (2016). HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies. Oncogene. doi:10.1038/onc.2015.506
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Costanza, B., Blomme, A., Bellahcene, A., Peulen, O., MUTIJIMA NZARAMBA, E., DELVENNE, P., De Pauw, E., DETRY, O., COIMBRA MARQUES, C., Castronovo, V., & Turtoi, A. (2016). EXPEL: A Novel Non-Destructive Method for Mining Soluble Tumor Biomarkers. Acta Gastro-Enterologica Belgica, 79 (1), 11.
Peer Reviewed verified by ORBi

Hendrick, E., Peixoto, P., Polese, C., Matheus, N., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Eppe, G., Castronovo, V., & Mottet, D. (03 December 2015). Compensatory Metabolism Promotes Cancer Cell Adaptation to HDAC5 Silencing [Poster presentation]. Séminaires des chercheurs Télévie 2016, Gembloux, Belgium.

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Turtoi, A., Costanza, B., Smargiasso, N., Baiwir, D., Leenders, J., De Tullio, P., BIANCHI, E., Thiry, M., Uchida, K., Spiegel, D., Cochrane, J., Hutton, C., De Pauw, E., ... Bellahcene, A. (29 September 2015). Methylglyoxal, a glycolysis side-product, induces Hsp90 post-translational glycation and YAP-mediated breast tumor growth and metastasis [Poster presentation]. Cancer and Metabolism Conference, Cambridge, United Kingdom.

Henry, A., Bellahcene, A., Castronovo, V., Peixoto, P., Goffart, N., Lallemand, F., Leroi, N., Peulen, O., MARTINIVE, P., Habraken, Y., Turtoi, A., Rogister, B., & Blomme, A. (Other coll.). (10 September 2015). Osteopontin as a new target in glioblastoma progression and resistance to radiotherapy [Paper presentation]. II International Symposium on clinical and basic investigation in glioblastoma, Toledo, Spain.

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Smargiasso, N., De Tullio, P., BIANCHI, E., Baiwir, D., Thiry, M., Turtoi, A., De Pauw, E., DELVENNE, P., Castronovo, V., & Bellahcene, A. (09 September 2015). Methylglyoxal, a glycolysis side-product, induces Hsp90 post-translational glycation and YAP-mediated breast tumor growth and metastasis [Poster presentation]. Metabolism in Cancer and Stromal Cells, Leuven, Belgium.

Costanza, B., Blomme, A., MUTIJIMA NZARAMBA, E., DELVENNE, P., DETRY, O., Castronovo, V., & Turtoi, A. (March 2015). Expel: a novel non-destructive method for mining soluble tumor biomarkers. Acta Gastro-Enterologica Belgica, 78 (1), 13.
Peer Reviewed verified by ORBi

Perez Palacios, A., Blomme, A., Boutry, S., Doumont, G., Sherer, F., Van Simaeys, G., Debois, D., JERUSALEM, G., COLLIGNON, J., DELVENNE, P., DETRY, O., De Pauw, E., Muller, R., Goldman, S., Castronovo, V., & Turtoi, A. (March 2015). Metabolomic, proteomic and preclinical imaging of patient-derived tumor xenografts for improving treatment of liver metastases patients. Acta Gastro-Enterologica Belgica, 78 (1), 134.
Peer Reviewed verified by ORBi

Hendrick, E., Peixoto, P., Polese, C., Matheus, N., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Sonveaux, P., Castronovo, V., & Mottet, D. (11 February 2015). HDAC5 Depletion in Cancer Cells Induces an Oxidative Stress and Leads to a Metabolic Reprogramming toward Glucose and Glutamine Metabolism [Poster presentation]. Seminaires des chercheurs Télévie 2015, Bruxelles, Belgium.

Blomme, A., Costanza, B., Thiry, M., De Tullio, P., Perez-Palacios, A., Mouithys-Mickalad, A., LIFRANGE, E., Delvenne, P., Castronovo, V., & Turtoi, A. (31 January 2015). Myoferlin Regulates Endosomal Trafficking and Tunes Cancer Cell Metabolism [Poster presentation]. ASSOCIATION BELGE POUR L'ETUDE DU CANCER "A.B.E.C» ANNUAL MEETING 2015: TUMOR METABOLISM AND MITOCHONDRIA, Louvain, Belgium.

Hendrick, E., Peixoto, P., Polese, C., Matheus, N., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Sonveaux, P., Castronovo, V., & Mottet, D. (31 January 2015). HDAC5 Depletion in Cancer Cells Induces an Oxidative Stress and Leads to a Metabolic Reprogramming toward Glucose and Glutamine Metabolism [Poster presentation]. ABEC TUmor Metabolism and Mitochondria, Bruxelles, Belgium.

Hendrick, E., Peixoto, P., Polese, C., Matheus, N., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Sonveaux, P., Castronovo, V., & Mottet, D. (27 January 2015). HDAC5 Depletion in Cancer Cells Induces an Oxidative Stress and Leads to a Metabolic Reprogramming toward Glucose and Glutamine Metabolism [Poster presentation]. Giga Cancer Day 2015 Current Advances in Medical Genetics and Genomics, Liège, Belgium.

Blomme, A., Costanza, B., Thiry, M., De Tullio, P., Perez Palacios, A., LIFRANGE, E., DELVENNE, P., Castronovo, V., & Turtoi, A. (27 January 2015). Myoferlin regulates endosomal trafficking and tunes cancer cell metabolism [Poster presentation]. GIGA-DAY 2015: Current advances in medical genetics and genomics, Liège, Belgium.

Costanza, B., Blomme, A., Bellahcene, A., MUTIJIMA NZARAMBA, E., Peulen, O., & DELVENNE, P. (January 2015). EXPEL: A Novel Non-Destructive Method for Mining Soluble Tumor Biomarkers [Poster presentation]. Belgian Association Cancer Research.

Maris, P., Blomme, A., Palacios, A. P., Costanza, B., Bellahcene, A., BIANCHI, E., GOFFLOT, S., Drion, P., Trombino, G. E., Di Valentin, E., CUSUMANO, G., MAWEJA, S., JERUSALEM, G., Delvenne, P., LIFRANGE, E., Castronovo, V., & Turtoi, A. (2015). Asporin Is a Fibroblast-Derived TGF-beta1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer. PLoS Medicine, 12 (9), 1001871. doi:10.1371/journal.pmed.1001871
Peer Reviewed verified by ORBi

Turtoi, A., Blomme, A., & Castronovo, V. (2015). Intratumoral heterogeneity and consequences for targeted therapies. Bulletin du Cancer, 102 (1), 17-23. doi:10.1016/j.bulcan.2014.12.006
Peer Reviewed verified by ORBi

Blomme, A. (2014). Contribution towards understanding the role of Myoferlin during breast cancer progression [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/314799

Hendrick, E., Peixoto, P., Polese, C., Matheus, N., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Sonveaux, P., Castronovo, V., & Mottet, D. (30 September 2014). HDAC5 Depletion in Cancer Cells Induces an Oxidative Stress and Leads to a Metabolic Reprogramming toward Glucose and Glutamine Metabolism [Paper presentation]. Annual Mini symposium 2014, Liège, Belgium.

Hendrick, E., Peixoto, P., Polese, C., Matheus, N., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Sonveaux, P., Castronovo, V., & Mottet, D. (25 September 2014). HDAC5 Depletion in Cancer Cells Induces an Oxidative Stress and Leads to a Metabolic Reprogramming toward Glucose and Glutamine Metabolism [Poster presentation]. Metabolism and Cancer Nice, Nice, France.

Hendrick, E., Peixoto, P., Polese, C., Matheus, N., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Sonveaux, P., Castronovo, V., & Mottet, D. (19 May 2014). Glucose-dependent metabolic reprogramming in HDAC5-depleted cancer cells [Poster presentation]. Giga Cancer Day 2014 THE LYMPHATIC SYSTEM : THE BED AND BENCH POINT OF VIEWS, Liège, Belgium.

Hendrick, E., Peixoto, P., Polese, C., Matheus, N., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Sonveaux, P., Castronovo, V., & Mottet, D. (25 April 2014). Glucose-dependent metabolic reprogramming in HDAC5-depleted cancer cells [Poster presentation]. Reactive Oxygen Species in Cell Metabolism 11th Meeting of the FRS-FNRS contact group on oxidative stress and anti-oxidants 210th Meeting of the Belgian Society of Biochemistry and Molecular Biology, Belgium.

Castronovo, V., Blomme, A., Delvenne, P., DETRY, O., & Turtoi, A. (March 2014). TGF-B induced protein IG-H3 is essential for the growth of human liver metastases. Acta Gastro-Enterologica Belgica, 77 (1), 05.
Peer Reviewed verified by ORBi

Turtoi, A., Blomme, A., Debois, D., SOMJA, J., Delvaux, D., Patsos, G., Di Valentin, E., Peulen, O., MUTIJIMA NZARAMBA, E., De Pauw, E., Delvenne, P., DETRY, O., & Castronovo, V. (March 2014). Organized Proteomic Heterogeneity in Colorectal Cancer Liver Metastases and Implications for Therapies. Hepatology, 59 (3), 924-934. doi:10.1002/hep.26608
Peer Reviewed verified by ORBi

Turtoi, A., Blomme, A., Debois, D., SOMJA, J., De Pauw, E., DETRY, O., & Castronovo, V. (March 2014). Organized proteomic heterogeneity in colorectal liver metastases and implications for therapies. Acta Gastro-Enterologica Belgica, 77 (1), 07.
Peer Reviewed verified by ORBi

Hendrick, E., Peixoto, P., Polese, C., Matheus, N., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Castronovo, V., & Mottet, D. (01 February 2014). Complex I Mitochondrial Dysfunction in HDAC5-depleted Cancer Cells Induces Glucose-dependent Metabolic Reprogramming [Poster presentation]. Association Belge pour l'étude du cancer A.B.E.C 2014, Anvers, Belgium.

Hendrick, E., Peixoto, P., Matheus, N., Polese, C., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Sonveaux, P., Castronovo, V., & Mottet, D. (27 January 2014). Complex I Mitochondrial Dysfunction in HDAC5-depleted Cancer Cells Induces Glucose-dependent Metabolic Reprogramming [Poster presentation]. Giga Day 2014, Liège, Belgium.

Costanza, B., Blomme, A., Bellahcene, A., Hennequière, V., LIFRANGE, E., DELVENNE, P., Castronovo, V., & Turtoi, A. (2014). Myoferlin is a Key Regulator of HER Receptor Family Function in Breast Cancer [Paper presentation]. EDT Annual Mini symposium 2014.

Turtoi, A.* , Blomme, A.* , BIANCHI, E., Maris, P., Vannozzi, R., Naccarato, A. G., DELVENNE, P., De Pauw, E., Bevilacqua, G., & Castronovo, V. (2014). Accessibilome of human glioblastoma: collagen-VI-alpha-1 is a new target and a marker of poor outcome. Journal of Proteome Research, 13 (12), 5660-5669. doi:10.1021/pr500657w
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Hendrick, E., Matheus, N., Peixoto, P., Polese, C., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., Elmoualij, B., De Tullio, P., Castronovo, V., & Mottet, D. (05 December 2013). HDAC5 depletion Decreases NDUFB5 Subunit of Mitochondrial Complex- I leading to Glucose-dependent Metabolic Reprogrammation [Poster presentation]. Séminaire des chercheurs Télévie 2014, Bruxelles, Belgium.

Hendrick, E., Matheus, N., Peixoto, P., Polese, C., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Castronovo, V., & Mottet, D. (13 September 2013). Complexe I mitochondrial dysfunction in HDAC5 depleted cancer cells induces glucose-dependent metabolic reprogrammation [Poster presentation]. Annual Mini symposium 2013, Bruxelles, Belgium.

Warnock, G., Turtoi, A., Blomme, A., Bretin, F., Bahri, M. A., Lemaire, C., Libert, L., Seret, A., Luxen, A., Castronovo, V., & Plenevaux, A. (22 August 2013). In vivo PET/CT in a human glioblastoma chicken chorioallantoic membrane model: A new tool for oncology and radiotracer development. Journal of Nuclear Medicine, 54 (10), 1782-1788. doi:10.2967/jnumed.112.117150
Peer Reviewed verified by ORBi

Hendrick, E., Matheus, N., Peixoto, P., Polese, C., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Castronovo, V., & Mottet, D. (17 May 2013). Mitochondrial dysfunction in HDAC5-depleted cancer cells induces glucose-dependent metabolic adaptation [Poster presentation]. GIGA-Cancer Day 2013, Liège, Belgium.

Turtoi, A.* , Blomme, A.* , Bellahcene, A., Gilles, C., Hennequière, V., Peixoto, P., BIANCHI, E., Noël, A., De Pauw, E., LIFRANGE, E., Delvenne, P., & Castronovo, V. (2013). Myoferlin is a key regulator of EGFR activity in breast cancer. Cancer Research, 73, 5438-5448. doi:10.1158/0008-5472.CAN-13-1142
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Warnock, G., Turtoi, A., Blomme, A., Gonzalez, A., Bretin, F., Bahri, M. A., Lemaire, C., Seret, A., Castronovo, V., Luxen, A., & Plenevaux, A. (October 2012). In Ovo PET Imaging Of A Human Colorectal Carcinoma Model In Chicken Chorioallantoic Membrane [Poster presentation]. Annual Congress of the European Association of Nuclear Imaging, Milan, Italy.

Blomme, A., Turtoi, A., & Castronovo, V. (September 2012). Imaging Guided Proteomics Unveils Heterogeneity in Colorectal Carcinoma Liver Metastases – Implications for Targeted Therapies [Paper presentation]. HUPO Meeting 2012, Boston, United States.

Blomme, A., Turtoi, A., Delvaux, D., Patsos, G., Somja, J., Debois, D., Delvenne, P., Warnock, G., Plenevaux, A., Luxen, A., Drion, P., DETRY, O., De Pauw, E., & Castronovo, V. (2012). Imaging Guided Proteomics Unveils Heterogeniety in Colorectal Carcinoma Liver Metastases – Implications for Targeted Therapies. In Proceedings Giga Day 2012.

Turtoi, A., Blomme, A., Delvaux, D., Dumont, B., SOMJA, J., Debois, D., DELVENNE, P., De Pauw, E., DE ROOVER, A., Honoré, P., DETRY, O., & Castronovo, V. (May 2012). INTRA-TUMORAL HETEROGENEITY AND RATIONAL SELECTION OF ANTIGENS FOR TARGETED THERAPY OF LIVER METASTASES. Acta Chirurgica Belgica, 112 (3), 89.FP53.
Peer Reviewed verified by ORBi

Turtoi, A., Blomme, A., & Castronovo, V. (24 April 2012). Rational selection of antigens for targeted therapy of liver metastases [Paper presentation]. Experimental Biology 2012, SAN DIEGO, United States.

Turtoi, A., Dumont, B., Greffe, Y., Blomme, A., Mazzucchelli, G., Delvenne, P., MUTIJIMA NZARAMBA, E., LIFRANGE, E., De Pauw, E., & Castronovo, V. (01 July 2011). Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues. Journal of Proteome Research, 10 (7), 3160-82. doi:10.1021/pr200212r
Peer Reviewed verified by ORBi

Castronovo, V., Blomme, A., Dumont, B., & Turtoi, A. (2011). Development of Targeted Therapies for Liver Metastases: Is Heterogeneity a Major Issue? [Paper presentation]. Annual Meeting at Experimental Biology, Washington DC, United States.
Peer reviewed

Blomme, A., Mac Cord, A., Sluse, F., & Mathy, G. (19 July 2010). Proteomic evolution of s.cerevisiae during chronological aging [Poster presentation]. XVIth european bioenergetics conference, Varsovie, Poland.

Gérin, S., Mathy, G., Blomme, A., Franck, F., & Sluse, F. (2010). Plasticity of the mitoproteome to nitrogen sources (nitrate and ammonium) in Chlamydomonas reinhardtii: the logic of Aox1 gene localization. Biochimica et Biophysica Acta. Bioenergetics, 1797, 994-1003. doi:10.1016/j.bbabio.2010.02.034
Peer Reviewed verified by ORBi

Mathy, G., Cardol, P., Dinant, M., Blomme, A., Gérin, S., Ghysels, B., Cloes, M., De Pauw, E., Leprince, P., Remacle, C., Sluse-Goffart, C., Franck, F., Matagne, R.-F., & Sluse, F. (2010). Proteomic and functional characterization of a Chlamydomonas reinhardtii mutant lacking the mitochondrial alternative oxidase 1. Journal of Proteome Research, 9, 2825-2838. doi:10.1021/pr900866e
Peer Reviewed verified by ORBi

Contact ORBi